Tag: ACADIA Pharmaceuticals Inc.

Total 15 Posts

Healthcare Analysts Reiterate Mixed Ratings on Valeant Pharmaceuticals Intl Inc (VRX) and ACADIA Pharmaceuticals Inc. (ACAD); Here’s Why

biotech 3Analysts weighed in today on biopharmaceutical giants Valeant Pharmaceuticals Intl Inc and ACADIA Pharmaceuticals Inc. in light of recent company updates. While Valeant is facing a more bearish outlook, Acadia received FDA approval for its lead drug and maintains a slightly more bullish outlook.